Currently out of the existing stock ratings of George Farmer, 50 are a BUY (51.02%), 47 are a HOLD (47.96%), 1 are a SELL (1.02%).

George Farmer

Work Performance Price Targets & Ratings Chart

Analyst George Farmer, currently employed at SCOTIABANK, carries an average stock price target met ratio of 62.87% that have a potential upside of 20.02% achieved within 85 days.

George Farmer’s has documented 189 price targets and ratings displayed on 22 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on BMRN, Biomarin Pharmaceutical at 20-Feb-2025.

Wall Street Analyst George Farmer

Analyst best performing recommendations are on JANX (JANUX THERAPEUTICS).
The best stock recommendation documented was for MRNA (MODERNA) at 11/17/2020. The price target of $109 was fulfilled within 8 days with a profit of $15.85 (17.02%) receiving and performance score of 21.27.

Average potential price target upside

of $36.42 (66.41%) on MYOK (MYOKARDIA).
of $26.08 (40.65%) on MRNA (MODERNA).
of $25.51 (38.86%) on BPMC (BLUEPRINT MEDICINES CORP).

BMRN Biomarin Pharmaceutical BPMC Blueprint Medicines Corp EXEL Exelixis INCY yte MRNA Moderna BIIB Biogen AGIO Agios Pharm ARVN Arvinas MRTX Mirati Ther MYOK MyoKardia NKTR Nektar Therapeutics PTGX Protagonist Therapeutics ARGX argenx NV ADR AURA Aura Biosciences SAGE Sage Therapeutic SNDX Syndax Pharmaceuticals ACLX Arcellx BMEA Biomea Fusion INMB INmune Bio JANX Janux Therapeutics KURA Kura Oncology LEGN Legend Biotech Corp

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Eliana Merle (UBS)